Halozyme therapeutics, inc. (HALO)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating activities:
Net (loss) income

-80,139

-72,240

-39,969

-42,804

-51,073

-80,330

45,678

76,277

68,407

62,971

-88,297

-119,992

-116,104

-103,023

-71,319

-66,833

-36,939

-32,231

-41,823

-37,643

-56,935

-68,375

-85,088

-84,100

-90,739

-83,479

-65,897

-66,611

-57,720

-53,552

-67,561

-42,390

-25,253

-19,769

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation

29,832

34,776

36,559

37,187

36,832

35,696

34,086

32,981

31,694

30,670

30,010

28,903

27,083

25,585

24,093

22,991

22,525

20,838

19,797

18,420

16,109

15,274

13,463

11,591

10,436

9,538

9,126

8,745

8,591

8,349

8,015

7,850

6,793

5,569

0

0

0

Depreciation and amortization

4,000

4,100

3,600

3,200

2,834

2,400

2,332

2,228

2,164

2,200

2,302

2,460

2,513

2,400

2,225

1,973

1,745

1,677

1,676

1,738

1,786

1,762

1,638

1,475

1,329

1,227

1,175

1,161

1,136

1,079

1,040

992

1,007

1,095

0

0

0

Non-cash interest expense

-

-

-

-

-

-

-

-

-

1,761

2,830

2,969

3,295

2,896

2,802

2,558

2,125

1,243

1,300

1,375

1,451

2,025

729

581

432

156

0

0

0

-

-

-

-

-

-

-

-

Payment-in-kind Interest expense on long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

552

10,031

6,357

2,769

879

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of discounts on marketable securities, net

0

2,469

3,129

3,553

0

3,090

2,375

1,635

0

303

-12,585

-12,849

-12,987

-13,184

194

151

112

0

-1,094

-1,318

-2,817

-1,457

-1,362

-1,306

101

-1,116

-816

-497

-182

0

0

0

0

-

-

-

-

Gain (Loss) on Disposition of Property Plant Equipment

0

-

-

-

0

-

-

-

-

-

-

-

-

-8

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-7

7

7

7

1

0

0

0

Contract with Customer, Liability, Revenue Recognized

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Deferral of unearned revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,379

2,863

3,513

309

7,045

-653

13,616

17,227

9,297

9,024

-1,935

-1,970

2,962

3,978

-15,587

-14,746

-17,209

0

0

0

Recognition of deferred revenue

-

-

-

-

-

2,832

4,653

6,023

6,623

6,512

5,391

8,373

9,503

9,304

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease payments deferred

-587

-459

-389

-368

-232

-7

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Recognition of deferred rent

-

-

-

-

-

-

-

-

-

185

235

272

414

370

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other

-22

-7

0

12

4

-9

-64

-80

-57

-16

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable, net

1,585

29,437

13,088

-1,363

1,590

-11,613

-6,524

-376

-5,363

6,453

-2,983

-8,754

-13,091

-16,730

9,286

13,489

17,818

23,261

117

-3,157

-3,231

52

-16,247

2,063

580

-6,606

20,058

5,145

4,825

13,441

-1,773

1,191

3,819

-65

0

0

0

Inventories

10,211

6,734

17,767

35,497

26,848

17,480

8,954

-6,768

-9,896

-9,477

-3,521

4,417

3,945

5,134

1,751

3,032

2,863

3,083

4,185

609

717

236

3,069

4,647

4,027

3,499

1,660

682

1,240

2,103

2,082

1,700

1,248

373

0

0

0

Prepaid expenses and other assets

14,355

19,006

12,528

10,082

574

5,695

14,440

14,807

8,572

-2,035

-13,539

-13,195

-12,816

-5,626

13,689

14,218

17,453

15,774

1,363

2,473

856

265

-39

-2,677

-496

-1,959

-618

2,480

2,632

4,421

7,055

6,517

5,527

4,611

0

0

0

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

100

50

50

50

-50

0

0

0

-

-

-

-

Accounts payable and accrued expenses

-15,102

4,638

2,253

13,572

9,459

5,696

9,186

9,897

9,364

15,629

4,234

4,110

-1,058

-244

6,454

7,364

10,510

13,866

3,502

-2,299

-5,444

-816

-6,490

-1,468

9,326

7,888

14,914

12,868

2,327

-3,263

788

-1,806

-125

711

0

0

0

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

23

2

-18

-48

0

0

0

-

-

-

-

172

0

0

0

Net cash provided by (used in) operating activities

-85,843

-85,423

-48,336

-37,675

-31,747

-49,500

93,287

132,473

134,335

134,053

-34,963

-63,970

-59,819

-50,383

-49,813

-58,050

-36,267

-37,083

-22,825

-19,023

-43,727

-47,518

-61,799

-61,030

-56,219

-49,339

-50,987

-52,871

-55,671

-64,279

-60,914

-60,060

-42,565

-34,300

0

0

0

Investing activities:
Purchases of marketable securities

285,346

389,759

280,051

334,881

364,121

311,112

472,082

446,210

458,018

398,187

201,756

178,905

83,811

155,412

177,526

176,697

164,728

71,482

46,127

32,952

57,064

88,884

89,117

89,116

65,005

48,947

48,947

48,947

48,947

0

0

0

0

-

-

-

-

Proceeds from maturities of marketable securities

291,582

388,250

414,601

462,852

436,078

318,268

317,228

286,276

256,211

235,805

208,994

164,369

119,069

81,783

69,283

80,413

78,743

79,730

81,215

50,410

57,971

57,301

47,191

44,191

25,600

3,375

0

0

0

-

-

-

-

-

-

-

-

Purchases of property and equipment

3,227

4,040

6,472

5,701

4,751

4,663

2,450

2,278

2,090

1,350

937

1,200

2,137

3,137

4,324

4,236

3,329

2,360

962

997

1,087

1,368

2,490

2,444

2,174

2,297

1,478

1,321

1,947

1,413

1,430

1,301

625

828

0

0

0

Proceeds from Sale of Property, Plant, and Equipment

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Net cash (used in) provided by investing activities

3,747

-5,549

128,078

122,270

67,206

2,493

-157,304

-162,212

-203,897

-163,732

6,301

-15,736

33,121

-76,766

-112,567

-100,520

-89,314

5,888

34,126

16,461

-180

-32,951

-44,416

-47,369

-41,579

-47,869

-50,425

-50,268

-50,909

-1,413

-1,430

-1,301

-609

-828

0

0

0

Financing activities:
Proceeds from issuance of common stock, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

107,713

107,713

107,713

107,713

0

0

0

0

81,477

0

0

0

-

-

-

-

Proceeds from issuance of long-term debt, net

-

-

-

-

-

-

-

-

-

-

-

-

-

203,006

203,005

203,005

148,046

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of long-term debt

103,500

108,082

83,715

82,346

81,169

77,516

62,106

46,745

30,634

15,995

10,953

6,393

53,354

54,250

54,285

54,250

3,885

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of Debt Issuance Costs

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments for Repurchase of Common Stock

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

Proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement

34,390

14,224

8,156

9,619

8,293

13,719

16,746

16,911

18,146

12,776

7,929

4,737

1,187

1,865

3,353

3,279

6,226

13,098

13,838

14,196

11,624

6,788

7,400

8,534

7,343

5,079

2,079

-157

89

1,680

0

0

0

-

-

-

0

Net cash provided by financing activities

126,321

153,215

-75,559

-72,727

-72,876

-63,797

-45,361

-29,833

122,386

131,655

131,852

133,218

2,793

150,621

152,073

152,034

150,387

13,098

13,838

14,196

11,624

114,501

135,098

136,606

135,350

25,064

31,740

29,476

29,441

112,818

83,680

84,336

86,004

4,748

0

0

0

Net increase (decrease) in cash, cash equivalents and restricted cash

44,225

62,243

4,183

11,868

-37,417

-110,804

-109,378

-59,572

52,824

101,976

103,190

53,512

-23,905

23,472

-10,307

-6,536

24,806

-18,097

25,139

11,634

-32,283

34,032

28,883

28,207

37,552

-72,144

-69,672

-73,663

-77,139

47,126

21,335

22,974

42,829

-30,380

0

0

0

Supplemental disclosure of cash flow information:
Interest Paid, Including Capitalized Interest, Operating and Investing Activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19

0

0

0

-

-

-

-

Supplemental disclosure of non-cash investing and financing activities:
Amounts accrued for purchases of property and equipment

208

61

-1,552

1,022

565

542

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

154

691

204

801

189

0

0

0

Right-of-use assets obtained in exchange for lease obligation

2,321

897

897

165

165

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments for Tenant Improvements

-

-

-

-

-

1,322

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-